Kampanjeplan Omeros Corporation
Avansert tidsplan
Enkel graf
Om selskapet Omeros Corporation
Omeros Corporation, коммерческая биофармацевтическая компания, обнаруживает, разрабатывает и коммерциализирует низкомолекулярные и белковые терапевтические препараты, а также показания для лечения больных с воспалениями, заболеваниями, опосредованными комплементом, нарушениями центральной нервной системы (ЦНС) и заболеваниями, связанными с иммунитетом. Он предоставляет OMIDRIA для использования при хирургии катаракты или замене интраокулярных линз в США. flere detaljer| IPO date | 2009-10-08 |
|---|---|
| ISIN | US6821431029 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.omeros.com |
| Цена ао | 8.52 |
| Prisendring per dag: | -6.99% (9.16) |
|---|---|
| Prisendring per uke: | -5.12% (8.98) |
| Prisendring per måned: | -1.84% (8.68) |
| Prisendring over 3 måneder: | -14.8% (10) |
| Prisendring over seks måneder: | +117.35% (3.92) |
| Prisendring per år: | +149.12% (3.42) |
| Prisendring over 3 år: | +43.92% (5.92) |
| Prisendring over 5 år: | -23.24% (11.1) |
| Prisendring siden begynnelsen av året: | -13.77% (9.88) |
|
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institusjoner | Volum | Dele, % |
|---|---|---|
| Corient Private Wealth LLC | 624 | 1.08 |
| Bank of Montreal/Can/ | 563 | 0.97 |
| Northern Trust Corporation | 554 | 0.96 |
| Ingalls & Snyder | 5 | 8.11 |
| Blackrock Inc. | 4 | 7.27 |
| Vanguard Group Inc | 3 | 5.61 |
| Stifel Financial Corporation | 2 | 3.29 |
| Shaw D.E. & Co., Inc. | 2 | 2.9 |
| Geode Capital Management, LLC | 1 | 2.38 |
| State Street Corporation | 1 | 2.13 |
| ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.05556 | 17.09 | 1.54048 |
| Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.0189 | 31.36 | 1.41955 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 23.05 | 0.60264 |
| Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
Schwab U.S. Small-Cap ETF
|
0.00604 | 17.47 | 1.51433 |
iShares Russell 2000 Growth ETF
|
0.0057 | 38.04 | 0.6026 |
ProShares UltraPro Russell2000
|
0.00474 | 89.82 | 1.47873 |
| ProShares Hedge Replication ETF | 0.00135 | 5.92 | 1.47892 |
| iShares Russell 3000 ETF | 0.00052 | 24.83 | 1.43482 |
Schwab U.S. Broad Market ETF
|
0.00044 | 24.86 | 1.43354 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| 0.01 | 29.22 | 1.31 |
| Veileder | Stillingstittel | Betaling | Fødselsår |
|---|---|---|---|
| Mr. Peter B. Cancelmo J.D. | VP, General Counsel & Corporate Secretary | 503.24k | 1979 (46 år) |
| Dr. George A. Gaitanaris M.D., Ph.D. | Chief Scientific Officer & VP of Science | N/A | 1957 (68 år) |
| Mr. Peter W. Williams | Vice President of Human Resources | N/A | 1968 (57 år) |
| Ms. Nadia Dac | VP & Chief Commercial Officer | N/A | 1970 (55 år) |
| Dr. Gregory A. Demopulos M.D. | Co-Founder, Chairman, CEO & President | 1.79M | 1959 (66 år) |
| Dr. Pamela Pierce Palmer M.D., Ph.D. | Co-Founder | N/A | 1963 (62 år) |
| Dr. Catherine A. Melfi Ph.D. | Chief Regulatory Officer & VP of Regulatory Affairs and Quality Systems | N/A | 1959 (66 år) |
| Dr. Andreas Grauer M.D. | VP & Chief Medical Officer | N/A | 1961 (64 år) |
| Mr. David J. Borges | VP of Finance, Chief Accounting Officer & Treasurer | 1964 (61 år) |
Adresse: United States, Seattle, WA , The Omeros Building - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.omeros.com
Nettsted: https://www.omeros.com
